Impact of the Living Donor Age and the Hormonal Profile of Algerian Renal Transplant Recipients

Autor:	Djebli-Azzal N; Department of Cellular and Molecular Biology Institute of Biology, University of Sciences and Technologies Houari Boumedienne, Algiers, Algeria., Benazzoug Y; Department of Cellular and Molecular Biology Institute of Biology, University of Sciences and Technologies Houari Boumedienne, Algiers, Algeria., Arab M; Department of Biochemistry, Central Laboratory of Biology, Algiers, Algeria., Rayane T; Department of Nephrology, N'Fissa Hamoud Hospital, Algiers, Algeria., Abib L; Pierre et Marie Curry Center, Endocrinology Laboratory, Algiers, Algeria., Cherifi MEH; Department of Biochemistry, Central Laboratory of Biology, Bainem Hospital, Algiers, Algeria.
Jazyk:	angličtina
Zdroj:	Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia [Saudi J Kidney Dis Transpl] 2021 Sep-Oct; Vol. 32 (5), pp. 1374-1381.
DOI:	10.4103/1319-2442.344757
Abstrakt:	Kidney transplantation is the best treatment received by an uremic patient. One of the major advantages of transplantation is restoring a hormonal profile as before the chronic kidney disease. However, the posttransplant state depends on several factors including the quality of the graft. In this study, we assessed the donor age in living donors-recipients as well as the exploration of their hormonal profile. This is a single-center follow-up study over a period of 3 years, including 90 kidney recipients transplanted by living donors. We performed blood measurements of parathyroid hormone, prolactin, follicle stimulating hormone, luteinizing hormone, testosterone, estradiol, blood glucose, urea, creatinine, total cholesterol, triglycerides, high density lipoprotein-cholesterol, uric acid, albumin, and 24-h proteinuria. Glomerular filtration rate, body mass index, and low-density cholesterol were calculated. To analyze the donor age effect on recipients, the patients were divided into two groups according to donors age (<40 years and ≥40 years). The hormonal profile was normal for almost the majority of patients. In addition, we noted a return to dialysis associated with certain metabolic abnormalities and a donor age >40 years. Exploring the hormonal profile of the recipient is recommended. The donor age significantly influences the recipient fate but not their hormonal profile. Competing Interests: None
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu